Cargando…

Recombinant SARS-CoV-2 Spike Protein Mediates Glycolytic and Inflammatory Activation in Human Monocytes

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) in part through cytokine storm. Metabolic reprogramming in immune cells mediates inflammation, and recent evidence suggests SARS-CoV-2 activates glycolysis in monocytes to facilitate cytokine prod...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pence, Brandt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740511/ http://dx.doi.org/10.1093/geroni/igaa057.3493

Ejemplares similares

Metformin Suppresses Monocyte Immunometabolic Activation by SARS-CoV-2 Spike Protein Subunit 1
por: Cory, Theodore J., et al.
Publicado: (2021)

Platelets mediate inflammatory monocyte activation by SARS-CoV-2 spike protein
por: Li, Tianyang, et al.
Publicado: (2022)

Classical monocytes maintain ex vivo glycolytic metabolism and early but not later inflammatory responses in older adults
por: Pence, Brandt D., et al.
Publicado: (2019)

Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming
por: Umar, Sadiq, et al.
Publicado: (2022)

Effects of Different Types of Recombinant SARS-CoV-2 Spike Protein on Circulating Monocytes’ Structure
por: Vettori, Marco, et al.
Publicado: (2023)

A urine-based ELISA with recombinant non-glycosylated SARS-CoV-2 spike protein for detecting anti-SARS-CoV-2 spike antibodies
por: Ramos, Fernanda F., et al.
Publicado: (2023)

Recombinant protein targeting and opsonizing spike glycoprotein for enhancing SARS-CoV-2 phagocytosis
por: Khattabi, Latifa
Publicado: (2020)

A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2
por: Wang, Maopeng, et al.
Publicado: (2020)

Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
por: Zhang, Yong, et al.
Publicado: (2021)

Cell-Free Glycoengineering of the Recombinant SARS-CoV-2 Spike Glycoprotein
por: Ruhnau, Johannes, et al.
Publicado: (2021)

249. SARS-CoV-2 Spike Immune Complexes Induce NETosis in COVID-19
por: Allen, Kiana C, et al.
Publicado: (2023)

Structure of SARS-CoV-2 spike protein
por: Zhang, Jun, et al.
Publicado: (2021)

Amyloidogenesis of SARS-CoV-2 Spike Protein
por: Nyström, Sofie, et al.
Publicado: (2022)

SARS-CoV-2 and the spike protein in endotheliopathy
por: Perico, Luca, et al.
Publicado: (2023)

Efficient production of recombinant SARS-CoV-2 spike protein using the baculovirus-silkworm system
por: Fujita, Ryosuke, et al.
Publicado: (2020)

Recombinant subunits of SARS‐CoV‐2 spike protein as vaccine candidates to elicit neutralizing antibodies
por: Noorabad Ghahroodi, Faezeh, et al.
Publicado: (2022)

SARS-CoV-2 recombinant spike protein induces cell apoptosis in rat taste buds
por: Yamamoto, Toru, et al.
Publicado: (2023)

A fast, efficient, and scalable method for purifying recombinant SARS-CoV-2 spike protein
por: Butani, Nikhila, et al.
Publicado: (2023)

The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2
por: Fang, Letian, et al.
Publicado: (2023)

290. Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in Children with COVID-19 and MIS-C
por: Avcu, Gulhadiye, et al.
Publicado: (2022)

Antibody-mediated immunity to SARS-CoV-2 spike
por: Errico, John M., et al.
Publicado: (2022)

SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination
por: Zhang, Zhengrong, et al.
Publicado: (2021)

LRRC15 mediates an accessory interaction with the SARS-CoV-2 spike protein
por: Shilts, Jarrod, et al.
Publicado: (2023)

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
por: Keech, Cheryl, et al.
Publicado: (2020)

Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein
por: Fan, Youpeng, et al.
Publicado: (2022)

Recombination in sarbecovirus lineage and mutations/insertions in spike protein are linked to the emergence and adaptation of SARS-CoV-2
por: Som, Anup, et al.
Publicado: (2022)

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

Binding of the SARS-CoV-2 spike protein to glycans
por: Hao, Wei, et al.
Publicado: (2021)

The roles of glycans in the SARS-CoV-2 spike protein
por: Casalino, Lorenzo, et al.
Publicado: (2022)

Proteolytic activation of SARS‐CoV‐2 spike protein
por: Takeda, Makoto
Publicado: (2021)

Mutations and Evolution of the SARS-CoV-2 Spike Protein
por: Magazine, Nicholas, et al.
Publicado: (2022)

Is the Stalk of the SARS-CoV-2 Spike Protein Druggable?
por: Pipitò, Ludovico, et al.
Publicado: (2022)

The Elusive Coreceptors for the SARS-CoV-2 Spike Protein
por: Berkowitz, Reed L., et al.
Publicado: (2022)

SARS-CoV-2 Spike Protein Interaction Space
por: Lungu, Claudiu N., et al.
Publicado: (2023)

583. SARS-CoV-2 Spike Protein S1/S2 Antibodies after Vaccination with Sinopharm in Peruvian Physicians
por: Lopera, Maria, et al.
Publicado: (2021)

Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV
por: Shekhawat, Uma, et al.
Publicado: (2022)

2636. Discovery of Spike Identification (SpiID) Nanobody Panel for SARS-CoV-2 Vaccine Development
por: Li, Qi, et al.
Publicado: (2023)

Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein
por: Wrobel, Antoni G., et al.
Publicado: (2020)

Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
por: Kemp, SA, et al.
Publicado: (2020)

Intermediates in SARS-CoV-2 spike–mediated cell entry
por: Marcink, Tara C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m4da3qkevhdj11sb45jk9h8ft2